NO970610L - Sammensetning for selektiv frigjöring av en aktiv ingrediens - Google Patents

Sammensetning for selektiv frigjöring av en aktiv ingrediens

Info

Publication number
NO970610L
NO970610L NO970610A NO970610A NO970610L NO 970610 L NO970610 L NO 970610L NO 970610 A NO970610 A NO 970610A NO 970610 A NO970610 A NO 970610A NO 970610 L NO970610 L NO 970610L
Authority
NO
Norway
Prior art keywords
composition
water
active ingredient
selective release
layer
Prior art date
Application number
NO970610A
Other languages
English (en)
Other versions
NO970610D0 (no
Inventor
Pawan Seth
Andre Stamm
Original Assignee
Pharma Pass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Pass filed Critical Pharma Pass
Publication of NO970610D0 publication Critical patent/NO970610D0/no
Publication of NO970610L publication Critical patent/NO970610L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse beskriver en sammensetning som omfatter følgende rekkefolge; (a) en kjerne av materiale som sveller i vann, (b) et elastisk vannuoppiøselig, vannpermeabelt lag, (c) et lag som inneholder en eller flere aktive ingredienser; og (d) et lag av et materiale som blir vannpermeabelt i et forutbestemt vandig medium, som er i stand til å ødelegges ved ekspansjon av kjernen. Anvendelse av nevnte sammensetning som et legemiddel er også beskrevet.
NO970610A 1994-08-11 1997-02-10 Sammensetning for selektiv frigjöring av en aktiv ingrediens NO970610L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9409963A FR2723536A1 (fr) 1994-08-11 1994-08-11 Composition permettant une liberation selective d'un principe actif
PCT/FR1995/001079 WO1996004893A1 (fr) 1994-08-11 1995-08-11 Composition permettant une liberation selective d'un principe actif

Publications (2)

Publication Number Publication Date
NO970610D0 NO970610D0 (no) 1997-02-10
NO970610L true NO970610L (no) 1997-03-21

Family

ID=9466272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970610A NO970610L (no) 1994-08-11 1997-02-10 Sammensetning for selektiv frigjöring av en aktiv ingrediens

Country Status (14)

Country Link
US (1) US5824341A (no)
EP (1) EP0774960A1 (no)
JP (1) JPH10504300A (no)
KR (1) KR970704428A (no)
AU (1) AU698240B2 (no)
CA (1) CA2197234A1 (no)
CZ (1) CZ41297A3 (no)
FI (1) FI970530A (no)
FR (1) FR2723536A1 (no)
HU (1) HUT77387A (no)
NO (1) NO970610L (no)
NZ (1) NZ290848A (no)
PL (1) PL318586A1 (no)
WO (1) WO1996004893A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6511477B2 (en) * 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US20020131908A1 (en) * 2000-01-13 2002-09-19 George Benda Selective release apparatus for fluids
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
US20030118647A1 (en) * 2001-12-04 2003-06-26 Pawan Seth Extended release tablet of metformin
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
US20040162320A1 (en) * 2003-02-14 2004-08-19 Pawan Seth Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant
US20040249364A1 (en) * 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2769760A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
WO2013047795A1 (ja) * 2011-09-30 2013-04-04 アステラス製薬株式会社 粒子状医薬組成物
KR101384055B1 (ko) * 2012-02-02 2014-04-14 한국원자력연구원 버스트형 지연 방출 제어 조성물 및 이의 제조방법
US20190083628A1 (en) * 2016-02-23 2019-03-21 Nipro Corporation Pharmaceutical composition particles and orally disintegrating preparation including the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
DE3629994A1 (de) * 1986-09-03 1988-03-17 Weissenbacher Ernst Rainer Pro Vorrichtung zur medikamentenapplikation in koerperhoehlen bzw. auf koerperoberflaechen
JPH01501719A (ja) * 1986-12-09 1989-06-15 スカイ　パーク　アクチーボラグ 車両移動装置
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
NZ242065A (en) * 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
JP2892858B2 (ja) * 1991-05-15 1999-05-17 田辺製薬株式会社 放出制御製剤およびその製造法
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ

Also Published As

Publication number Publication date
CA2197234A1 (fr) 1996-02-22
FR2723536A1 (fr) 1996-02-16
HUT77387A (hu) 1998-04-28
JPH10504300A (ja) 1998-04-28
FI970530A (fi) 1997-04-08
AU3169995A (en) 1996-03-07
KR970704428A (ko) 1997-09-06
CZ41297A3 (cs) 1998-05-13
NZ290848A (en) 1998-03-25
PL318586A1 (en) 1997-06-23
FI970530A0 (fi) 1997-02-07
EP0774960A1 (fr) 1997-05-28
US5824341A (en) 1998-10-20
WO1996004893A1 (fr) 1996-02-22
NO970610D0 (no) 1997-02-10
AU698240B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
DK0779807T3 (da) Fremgangsmåde til fremstilling af en kappetablet med spids kerne
DK1398A (da) Antifungalt middel, forbindelse til dette, fremgangsmåde til fremstilling af denne og metode til dets anvendelse
PT98571A (pt) Dispositivos para a libertacao controlada que utilizam membranas polimerizadas interfacialmente e de processos para a sua preparacao
NO980015D0 (no) Nye trombininhibitorer, deres fremstilling og anvendelse
DK0771788T3 (da) Substituerede sulfonimidamider, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnostikum og
BR9811099A (pt) Inibidores de urocinase
NO992408D0 (no) FremgangsmÕte for lavavfalls fremstilling av skiveformige formlegemer inneholdende aktive ingredienser, og transdermale terapeutiske systemer inneholdende samme
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
DK0795547T3 (da) (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk
NO985807L (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
NO993435L (no) Transdermalt acetylsalicylsyre inneholdende terapeutisk system med forsterket resorpsjon
DK0943030T3 (da) Fremgangsmåde til reduktion af svovl- og kypefarvestoffer
NO961677D0 (no) Nye cykloheksanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf
NO992859D0 (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
ATE215941T1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DK0810205T3 (da) Substituerede 1-naphthoylguanidiner, fremgangsmåde til deres fremstiling, deres anvendelse som lægemiddel eller diagnostisk middel samt lægemiddel indeholdende dem
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
NO307512B1 (no) Nye indolforbindelser, farmasøytisk preparat inneholdende slike forbindelser, og deres anvendelse
DK0946580T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application